Registration Open for DLBCL CAR T-Cell Case Discussion

An interactive case-based discussion on clinical decision-making and CAR T-cell therapy for DLBCL is accepting registrations. Stephen C. Medlin, DO, will moderate; he is an endowed chair and founding medical director of stem cell transplant and immunotherapy at Inova Health System.

The announcement concerns an interactive, case-based discussion on clinical decision-making and CAR T-cell therapy for DLBCL, and registration is open. Stephen C. Medlin, DO, will moderate. His listed credentials include endowed chair and founding medical director of stem cell transplant and immunotherapy at Inova Health System. Within the wider cancer research and health-medicine topic, the item highlights professional exchange around treatment choices, but it offers no study findings, patient outcomes, or policy changes.